Beauty Byte: FDA Approves Eyelash-Growth Drug

18

Back in June, the maker of Botox was seeking FDA approval of its eyelash-boosting drug. Now, Allergan got its wish: the FDA has approved Latisse, an eyelash-thickening agent meant for people who have hypotrichosis of the eyelashes — in other words, too few lashes.

Latisse's active ingredient is bimatroprost, which happens to be the same ingredient used in glaucoma treatments. Side effects may include itchy eyes, eye redness, a change in skin color, and a potentially permanent darkening of the iris. For people who have serious eyelash problems, it's probably worth a shot — but considering the possible side effects, I'll stick with my mascara for now.

Source

Take All of the Sauciest Quizzes on BellaSugar!
Take All of the Sauciest Quizzes on BellaSugar!
Something Else to Take From the Hotel For Your Next Trip
Something Else to Take From the Hotel For Your Next Trip